Afelimomab
Afelimomab (MAK 195F) is an anti-TNFα monoclonal antibody. Administration of afelimomab reduces the concentration of interleukin-6 in patients with sepsis, but reduces mortality only marginally.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Afelimomab
Afelimomab (MAK 195F) is an anti-TNFα monoclonal antibody. Administration of afelimomab reduces the concentration of interleukin-6 in patients with sepsis, but reduces mortality only marginally.
has abstract
Afelimomab (MAK 195F) is an an ...... ces mortality only marginally.
@en
L'afelimomab o MAK 195F è un a ...... mortalità solo marginalmente.
@it
أفيليموماب هو جسم مضاد وحيد ال ...... 6 في المرضى المصابين بالإنتان.
@ar
CAS number
156227-98-4
FDA UNII code
6SC756X51V
KEGG
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
977,977,810
Link from a Wikipage to another Wikipage
ATC prefix
L04
@en
ATC suffix
AB03
@en
CAS number
ChemSpiderID
none
@en
KEGG
D07436
@en
mab type
F2
@en
source
o
@en
target
type
mab
@en
Verifiedfields
changed
@en
verifiedrevid
477,243,250
wikiPageUsesTemplate
subject
hypernym
comment
Afelimomab (MAK 195F) is an an ...... ces mortality only marginally.
@en
L'afelimomab o MAK 195F è un a ...... mortalità solo marginalmente.
@it
أفيليموماب هو جسم مضاد وحيد ال ...... 6 في المرضى المصابين بالإنتان.
@ar
label
Afelimomab
@en
Afelimomab
@it
أفيليموماب
@ar